Rich’s 10 Best Stocks to Buy or Watch in April 2020

10 best stocks to buy

At the start of every month, Rich profiles some of the best stocks that his viewers should be watching. His list for February produced a few big winners, and despite the COVID-19 crash, his March list also saw some serious gains. Today, he starts the month off the same way by listing the 10 best stocks to buy or watch in April 2020.

Unfortunately, Rich is predicting that the hard times will continue. After major losses in late February and volatility throughout March, April may prove to be the cruelest month so far.

“I believe that April is going to be one of the worst months of the year for the market,” Rich explains. “Due to fears over the coronavirus, there’s going to be a lot of shorting and a lot of panic selling. There’s going to be serious downward pressure in April, so be careful.”

#10 Best Stocks to Buy or Watch in April: ProShares UltraPro Short Dow30 (NYSE:SDOW)

Because it’s a shorter’s market, Rich is recommending a statistically profitable, short-based ETF. SDOW seeks daily investment results corresponding to three times the inverse of the daily performance of the Dow Jones Industrial Average Index.

Enter Your E-mail Address To Subscribe

* indicates required

Basically, fund invests in financial instruments that ProShare Advisors believes should, in combination, produce consistent daily returns. SDOW is a price-weighted index and includes 30 blue-chip stocks, excluding utility and transportation companies.

“If you want to short the Dow Jones, this is the ETF,” says Rich. “It’s up 12% today at $54, but has been as high as $95. So if we see another big crash, this would be an amazing trade to hedge against market losses.”

#9 Best Stocks to Buy or Watch in April: Roche Holding AG (OTCQX:RHHBY)

Rich first profiled Roche Holding back in mid-March. The company is a Swiss multinational and the world’s largest biotech company. It has developed over 30 medicines that are now included in the WHO’s list of Essential Medicines.

RHHBY hit a low for the year-to-date on March 20 when it fell to $35.26. Since then, it has done nothing but gain value, rising to its current price of $40.80.

Roch is one of more than a dozen companies currently working on a potential COVID-19 cure. The company recently initiated a Phase 3 clinical trial evaluating its drug Actemra as a treatment for patients with COVID-19. Roche expects to enroll about 330 patients in the trial early this month.

“Donald Trump keeps mentioning this company’s name,” says Rich. “I think as we go into the eye of the coronavirus storm, we’ll see Roche go up.”

#8 Best Stocks to Buy or Watch in April: GW Pharmaceuticals (NASDAQ:GWPH)

GW Pharmaceuticals is a world leader in the science, development, and commercialization of cannabis-derived prescription medicines. Like the rest of the market, GWPH has been slaughtered by big losses in February and March, losing nearly half of its value in six weeks. However, things do seem to be turning around.

“They’ve been as low as $67,” says Rich. “They’re currently at $85, but this thing’s going to $100. There’s no doubt about it, so GWPH is great at these prices.”

Yesterday, the company announced that the FDA accepted for filing to review Epidiolex to treat seizures associated with Tuberous Sclerosis Complex. This is big news and is contributing to the stock’s rapid gains.

#7 Best Stocks to Buy or Watch in April…

For the rest of Rich’s list, be sure to check out his video. And remember, always do your own research before investing.

Featured image: DepositPhotos © davidewingphoto

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Bitrex Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.